Learn more

ADAMED SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    197,882
About

ADAMED SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA has a total of 16 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Poland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DENALI THERAPEUTICS INC, MEDICINES CO LEIPZIG GMBH and PALUMED SA.

Patent filings in countries

World map showing ADAMED SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIAs patent filings in countries
# Country Total Patents
#1 Poland 16

Patent filings per year

Chart showing ADAMED SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Majka Zbigniew 8
#2 Pieczykolan Jerzy Szczepan 4
#3 Kolaczkowski Marcin 3
#4 Pawlowski Maciej 3
#5 Sulikowski Daniel 3
#6 Pawlak Sebastian Dominik 3
#7 Jagodzinska Monika 2
#8 Zerek Bartlomiej 2
#9 Stawinski Tomasz 2
#10 Rozga Piotr Kamil 2

Latest patents

Publication Filing date Title
PL418713A1 Antineoplastic fusion protein
PL418019A1 Method for producing brexpiprazole, intermediate compounds used in this method and method for producing them
PL415332A1 Composition of a dietary medium
PL409397A1 Antiangiogenic lipopeptide, composition containing it and their application
PL409398A1 Cosmetic composition and its applications
PL406630A1 Composition of diet supplement
PL405987A1 Application of soluble starch
PL403282A1 Composition of dietary supplements containing fabacum
PL402191A1 Complex pharmaceutical composition comprising candesartan cilexetil and amlodipine, its preparation method and the unit dosage form comprising said composition,
PL397167A1 Anti-tumor fusion protein
PL395470A1 Alicyclic amines sulfonamide derivatives for the treatment of diseases of the central nervous system
PL395469A1 Indolamines derivatives for the treatment of diseases of the central nervous system
PL395468A1 Amido-alkilo-piperazine compounds for treating diseases of the central nervous system
PL394618A1 Anticancer fusion protein
PL373929A1 Method for the manufacture of N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyridine amine
PL373928A1 Method for the manufacture of imatinibe